Renliang Zhang
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 7
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 7
- Immunology top 1%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 7
- Physiology top 1%
- Nitric Oxide and Endothelin Effects 8
-
- Acute Ischemic Stroke Management 23
- Liver Disease Diagnosis and Treatment 8
-
- Cerebrovascular and Carotid Artery Diseases 22
-
- Intracranial Aneurysms: Treatment and Complications 12
-
- Peroxisome Proliferator-Activated Receptors 9
- Co-authors
- Stanley L. HazenZhongzhou ShenMingjiang SunXinfeng LiuGelin XuMaria FebbraioRoy L. SilversteinTakhar Kasumov
- Cited by
- BiochemistryImmunology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (1 paper)JAMA (1 paper)
- Partner nations
- United StatesChinaIsrael
In The Last Decade
Renliang Zhang
115 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Biochemistry 542
- Biochemistry 605
- Immunology 1.7k
- Physiology 1.3k
- Endocrine and Autonomic Systems 268
Countries citing papers authored by Renliang Zhang
This map shows the geographic impact of Renliang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renliang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renliang Zhang more than expected).
Fields of papers citing papers by Renliang Zhang
This network shows the impact of papers produced by Renliang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renliang Zhang. The network helps show where Renliang Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Renliang Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 11 | |
| 4 | 2022 | 12 | |
| 5 | 2022 | 17 | |
| 6 | 2022 | 15 | |
| 7 | 2015 | 10 | |
| 8 | 2013 | 4 | |
| 9 | 2012 | 39 | |
| 10 | 2011 | 21 | |
| 11 | 2010 | 230 | |
| 12 | 2009 | 35 | |
| 13 | 2009 | 53 | |
| 14 | 2006 | 98 | |
| 15 | 2006 | 50 | |
| 16 | 2006 | 38 | |
| 17 | 2006 | 111 | |
| 18 | 2003 | 42 | |
| 19 | 2002 | 377 | |
| 20 | 1999 | 17 |
About Renliang Zhang
Renliang Zhang is a scholar working on Neurology, Biophysics and Biochemistry, having authored 115 papers that have together received 7.0k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (23 papers), Cerebrovascular and Carotid Artery Diseases (22 papers), Intracranial Aneurysms: Treatment and Complications (12 papers), Peroxisome Proliferator-Activated Receptors (9 papers), Nitric Oxide and Endothelin Effects (8 papers), Liver Disease Diagnosis and Treatment (8 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers). The work is most often cited by research in Biochemistry (542 citations), Biochemistry (605 citations) and Immunology (1.7k citations). Renliang Zhang has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Stanley L. Hazen, Zhongzhou Shen, Mingjiang Sun, Xinfeng Liu, Gelin Xu, Maria Febbraio, Roy L. Silverstein, Takhar Kasumov, John P. Kirwan and Robert G. Salomon. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.